SCHEMBL16199860

SCHEMBL16199860

c1cc2ncsc2cc#1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL452437 0.80 — —
SCHEMBL857649 0.70 — —
SCHEMBL857488 0.70 — —
SCHEMBL4560336 0.65 ALDH1A1 (0.50) —
SCHEMBL1420202 0.62 — —
SCHEMBL5154375 0.61 ALDH1A1 (0.45) —
Benzo[D]Thiazole SCHEMBL3108778 0.60 ALDH1A1 (0.95) —
Benzo[D]Thiazole SCHEMBL3856663 0.60 ALDH1A1 (0.95) —
Benzo[D]Thiazole SCHEMBL2173015 0.60 ALDH1A1 (0.95) —
Benzo[D]Thiazole SCHEMBL3765441 0.60 ALDH1A1 (0.95) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2635556-B1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS PORTOLA PHARM INC (US) 2017-06-21 — — EP disclosed
EP-3176154-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS Portola Pharmaceuticals, Inc. (US) 2017-06-07 — — EP disclosed
EP-2321283-B1 2,6-DIAMINO-PYRIMIDIN-5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS PORTOLA PHARM INC (US) 2016-07-13 — — EP disclosed
EP-2323993-B1 2,6-DIAMINO- PYRIMIDIN- 5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS PORTOLA PHARM INC (US) 2015-06-03 — — EP disclosed
EP-2796456-A1 Bicyclic compounds as Pim inhibitors Amgen Inc. (US) 2014-10-29 — — EP disclosed
EP-2427194-B1 PYRROLIDINE-DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME (US) 2014-10-08 — — EP disclosed
Send feedback